AtriCure Inc (ATRC) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
AtriCure Inc - Key Facts
AtriCure Inc - Key Employees
AtriCure Inc - Key Employee Biographies
AtriCure Inc - Major Products and Services
AtriCure Inc - History
AtriCure Inc - Company Statement
AtriCure Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AtriCure Inc - Business Description
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other international
Performance
Geographical Segment: the US
Performance
R&D Overview
AtriCure Inc - Corporate Strategy
AtriCure Inc - SWOT Analysis
SWOT Analysis - Overview
AtriCure Inc - Strengths
AtriCure Inc - Weaknesses
AtriCure Inc - Opportunities
AtriCure Inc - Threats
AtriCure Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AtriCure Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
AtriCure Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
AtriCure Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 28, 2019: AtriCure reports fourth quarter and full year 2018 financial results
Jan 07, 2019: AtriCure reports preliminary results for fourth quarter and full year 2018
Nov 01, 2018: Atricure reports third quarter 2018 financial results
Aug 01, 2018: Atricure reports second quarter 2018 financial results
Jun 05, 2018: AtriCure and Baheal Group Establish Partnership and China Distribution Agreement
Apr 26, 2018: AtriCure Reports First Quarter 2018 Financial Results
Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results
Feb 20, 2018: AtriCure Names Scott Drake Board Chairman
Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
AtriCure Inc (ATRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
AtriCure, Inc. (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions. The company carries out the development, manufacture and sale of cardiac surgical ablation devices. Its major products include Isolator Synergy ablation system, a bipolar ablation clamp system; radio frequency ablation devices; cryoICE cryoablation system and AtriClip left atrial appendage (LAA) exclusion system. It also offers Lumitip dissectors and reusable cardiac surgery instruments. The company markets and sells its products in markets outside the US through its European subsidiaries and independent distributors. It has distributors in Asia Pacific, North America, South America, Europe, the Middle East, and Africa. AtriCure is headquartered in Mason, Ohio, the US.
AtriCure Inc Key Recent Developments
Feb 28,2019 AtriCure reports fourth quarter and full year 2018 financial results
Jan 07,2019 AtriCure reports preliminary results for fourth quarter and full year 2018
Nov 01,2018 Atricure reports third quarter 2018 financial results
Aug 01,2018 Atricure reports second quarter 2018 financial results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company